Fapon Biotech
A senior leadership role at El Capitan Biosciences focused on business development and strategic partnerships for their stool host RNA-seq platform, with emphasis on pharmaceutical collaborations in IBD and GI indications, as well as service and co-development opportunities. The role involves engaging with external stakeholders and supporting commercial strategies.
Headquarters
Dongguan, Guangdong, China
Company Size
1001-5000 employees
Founded
2001
Feipeng Biotech Co., Ltd. (菲鹏生物股份有限公司) is an in vitro diagnostics (IVD) platform company that develops and supplies high-performance core raw materials for IVD reagents, integrated reagent solutions, and open instrument platforms. Focused on future health management and biotechnology trends, it serves global IVD manufacturers across applications including chemiluminescence, molecular diagnostics, POCT, immunoturbidimetry, clinical chemistry and rapid testing. Feipeng provides end-to-end offerings—from upstream raw materials and reagent formulations to instrument ecosystems and ecological cooperation—emphasizing performance, technical innovation, and collaborative partnerships.
Headquarters
San Francisco, CA
Company Size
201-500 employees
Founded
2018
Industry
Technology
Glassdoor Rating
4.2 / 5
Sarah Johnson
Chief Executive Officer
Michael Chen
Chief Technology Officer
Emily Williams
VP of Engineering
David Rodriguez
VP of Product
Jessica Thompson
Chief Financial Officer
Andrew Park
VP of Sales
View leadership team, funding history,
and employee contacts for Fapon Biotech.
45% above the average for this role
Temporary Bioinformatics Analyst
University of North Carolina System
Assistant Professor-Research Track-Human B Cell Immunologist-Department of Pathology & Laboratory Medicine
University of Pennsylvania
Postdoctoral Researcher
Columbia University
Scientist, Platform RNA Sciences
Sail Biomedicines
Postdoctoral Fellow
The Wistar Institute
Scientist (Postdoctoral Fellow: Computational Methods for Long Read RNA-Seq data)
ASTARPRD